Medicare Enrolled
Dr. Nawid Sarwari, M.D.
Hematology & Oncology · Anaheim, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sarwari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarwari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sarwari
Dr. Nawid Sarwari is a hematology & oncology specialist in Anaheim, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Sarwari performed 1,336 Medicare services across 485 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sarwari received a total of $27,887 from 93 pharmaceutical and/or device companies across 939 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sarwari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 46% volume in CA
$27,887 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,336
Medicare services
Top 46% in CA for hematology & oncology
485
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (ondansetron/Zofran) | 336 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
244 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
196 | $100 | $273 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
167 | $8 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
122 | $69 | $193 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
46 | $12 | $29 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
46 | $116 | $299 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
31 | $23 | $62 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
29 | $59 | $147 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
27 | $1 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
26 | $24 | $64 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $108 | $281 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $100 | $235 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $126 | $350 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
11 | $68 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.6% high complexity
48.9% medium
43.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$27,887
Total received (2019-2024)
Avg $4,648/year across 6 years
Top 16% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
939
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,160 (68.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,258 (26.0%)
Other
Charitable contributions, space rental, and other categories
$1,468 (5.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,681
2023
$5,339
2022
$4,395
2021
$7,521
2020
$3,705
2019
$246
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,468
Astellas Pharma US Inc
$399
Merck Sharp & Dohme LLC
$308
Eisai Inc.
$296
PFIZER INC.
$286
Incyte Corporation
$271
Daiichi Sankyo Inc.
$248
ABBVIE INC.
$242
Janssen Biotech, Inc.
$218
Takeda Pharmaceuticals U.S.A., Inc.
$194
SOBI, INC
$187
AstraZeneca Pharmaceuticals LP
$177
GlaxoSmithKline, LLC.
$146
BeiGene USA, Inc.
$136
Gilead Sciences, Inc.
$133
Lilly USA, LLC
$129
Exelixis Inc.
$114
ARRAY BIOPHARMA INC
$101
PUMA BIOTECHNOLOGY, INC.
$101
TAIHO ONCOLOGY, INC.
$99
Alexion Pharmaceuticals, Inc.
$96
Rigel Pharmaceuticals, Inc.
$93
Deciphera Pharmaceuticals Inc.
$91
EMD Serono, Inc.
$84
PharmaEssentia USA Corporation
$80
Blueprint Medicines Corporation
$78
Celgene Corporation
$72
GENZYME CORPORATION
$68
Bayer Healthcare Pharmaceuticals Inc.
$67
E.R. Squibb & Sons, L.L.C.
$62
SpringWorks Therapeutics, Inc.
$52
Karyopharm Therapeutics Inc.
$49
Sumitomo Pharma America, Inc.
$44
Mirati Therapeutics, Inc.
$44
RECORDATI_RARE_DISEASES_INC.
$42
Regeneron Healthcare Solutions, Inc.
$37
Genmab U.S., Inc.
$32
Aveo Pharmaceuticals, Inc.
$30
Octapharma USA, Inc.
$30
Stemline Therapeutics Inc.
$28
Tolmar, Inc.
$25
Fennec Pharmaceuticals, Inc.
$24
Adaptive Biotechnologies Corporation
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Coherus Biosciences Inc.
$22
ImmunoGen, Inc.
$21
Pharmacosmos Therapeutics Inc.
$21
Kyowa Kirin, Inc.
$21
Tempus AI, Inc
$21
Ipsen Biopharmaceuticals, Inc
$19
PROGENICS PHARMACEUTICALS, INC.
$15
Agios Pharmaceuticals, Inc.
$15
Top 3 companies account for 32.6% of 2024 payments
All-time payments by company (2019-2024) ›
Pharmacosmos Therapeutics Inc.
$4,491
Novartis Pharmaceuticals Corporation
$2,368
ARRAY BIOPHARMA INC
$2,304
PFIZER INC.
$1,019
Incyte Corporation
$993
AstraZeneca Pharmaceuticals LP
$951
Celgene Corporation
$897
E.R. Squibb & Sons, L.L.C.
$818
Astellas Pharma US Inc
$767
Merck Sharp & Dohme LLC
$702
Takeda Pharmaceuticals U.S.A., Inc.
$665
Eisai Inc.
$657
GlaxoSmithKline, LLC.
$628
Amgen Inc.
$575
Janssen Biotech, Inc.
$557
Exelixis Inc.
$469
Daiichi Sankyo Inc.
$407
Gilead Sciences, Inc.
$364
Karyopharm Therapeutics Inc.
$349
Merck Sharp & Dohme Corporation
$340
Seagen Inc.
$330
Bayer Healthcare Pharmaceuticals Inc.
$323
ABBVIE INC.
$308
BeiGene USA, Inc.
$296
Rigel Pharmaceuticals, Inc.
$285
Alexion Pharmaceuticals, Inc.
$281
Kite Pharma, Inc.
$276
Regeneron Healthcare Solutions, Inc.
$263
SOBI, INC
$232
Pharmacyclics LLC, An AbbVie Company
$222
Lilly USA, LLC
$211
GENZYME CORPORATION
$208
Bayer HealthCare Pharmaceuticals Inc.
$193
EMD Serono, Inc.
$185
TAIHO ONCOLOGY, INC.
$164
PUMA BIOTECHNOLOGY, INC.
$162
Deciphera Pharmaceuticals Inc.
$158
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
Blueprint Medicines Corporation
$132
Puma Biotechnology, Inc.
$131
Novo Nordisk Inc
$122
Stemline Therapeutics Inc.
$116
Genentech USA, Inc.
$114
Sumitomo Pharma America, Inc.
$108
Mirati Therapeutics, Inc.
$106
Servier Pharmaceuticals LLC
$105
Adaptive Biotechnologies Corporation
$103
Novocure Inc.
$101
EISAI INC.
$96
Pharmacyclics LLC, an AbbVie Company
$95
MorphoSys, US Inc.
$93
AVEO Pharmaceuticals, Inc.
$92
CSL Behring
$91
Sobi, Inc
$89
Epizyme, Inc.,
$89
Taiho Oncology, Inc.
$88
AbbVie Inc.
$81
Foundation Medicine, Inc.
$80
PharmaEssentia USA Corporation
$80
ImmunoGen, Inc.
$74
Emmaus Medical, Inc.
$72
Myovant Sciences Inc.
$69
Alnylam Pharmaceuticals Inc.
$68
EUSA Pharma (US) LLC
$64
Ipsen Biopharmaceuticals, Inc
$64
Aveo Pharmaceuticals, Inc.
$58
Agios Pharmaceuticals, Inc.
$52
SpringWorks Therapeutics, Inc.
$52
Organon LLC
$48
Dova Pharmaceuticals
$43
RECORDATI_RARE_DISEASES_INC.
$42
Global Blood Therapeutics, Inc.
$35
Cumberland Pharmaceuticals, Inc.
$34
Genmab U.S., Inc.
$32
Octapharma USA, Inc.
$30
CTI BioPharma Corp.
$28
GE HEALTHCARE
$27
ADC Therapeutics America, Inc.
$25
Tolmar, Inc.
$25
Acrotech Biopharma LLC
$25
Fennec Pharmaceuticals, Inc.
$24
Dendreon Pharmaceuticals LLC
$23
Coherus Biosciences Inc.
$22
GE HealthCare
$22
Kyowa Kirin, Inc.
$21
Tempus AI, Inc
$21
Acceleron Pharma, Inc.
$18
Janssen Pharmaceuticals, Inc
$16
ACCORD HEALTHCARE, INC.
$15
PROGENICS PHARMACEUTICALS, INC.
$15
Acrotech Biopharma Inc.
$15
Secura Bio, Inc.
$12
Sirtex Medical Inc
$11
Top 3 companies account for 32.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Afstyla · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Elahere · Endari · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Fabhalta · Farydak · GAMIFANT · GILOTRIF · GIVLAARI · HEMADY · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idelvion · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · Monoferric · NERLYNX · NINLARO · NovoSeven RT · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Pedmark · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SYLVANT · SYNAGIS · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Vectibix · Vitrakvi · Vonjo · Vyloy · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
328
Per 100K population
10.4
County median income
$113,702
Nearest hospital
AHMC ANAHEIM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sarwari is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sarwari experienced with anti-nausea injection (ondansetron/zofran)?
Based on Medicare claims data, Dr. Sarwari performed 336 anti-nausea injection (ondansetron/zofran) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sarwari receive payments from pharmaceutical companies?
Yes. Dr. Sarwari received a total of $27,887 from 93 companies across 939 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarwari's costs compare to other hematology & oncology specialists in Anaheim?
Dr. Sarwari's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarwari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Anaheim
Browse hematology & oncology specialists in Anaheim ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Pharmacosmos Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Pharmacosmos Therapeutics Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ARRAY BIOPHARMA INC Payments to Doctors
See all physicians who received payments from ARRAY BIOPHARMA INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology